Yijun Deng

This inventor holds 27 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Cancer Therapeutics. Top assignees: Tetralogic Pharmaceuticals Corporation, Tetralogic Birinapant UK Ltd., Medivir Ab. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yijun Deng. Retrieved from https://idiyas.com/inventor/yijun-deng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 27 (Patent Applications = 10)

% Patents Active = 51.9

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 4.3

ph-index = 11

Forward Citations = 326(Granted Patents)

Location History:

Malvern, PA (US) (2013)
Dresher, PA (US) (2007 - 2024)

Company Filing History:

14 out of 15

Tetralogic Pharmaceuticals Corporation

patents

5 out of 5

Tetralogic Birinapant UK Ltd.

Viropharma Incorporated

Siga Technologies Inc.

patents

where one patent can have more than one assignee

Years Active: 2007-2024

Loading Chart...

Areas of Expertise:

SMAC Mimetic

IAP Inhibitors

Dimeric IAP Inhibitors

IAP Binding Compounds

Hepatitis C

Pharmaceutical Compositions

Arenaviruses

Myelodysplastic Syndromes

Sulfonyl Semicarbazides

Benzofuran Compounds

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11951147 - SMAC mimetic (2024-04-09),

2. 11351221 - SMAC mimetic (2022-06-07),

3. 10596220 - SMAC mimetic (2020-03-24),

4. 10314881 - SMAC mimetic (2019-06-11),

5. 10034912 - SMAC Mimetic (2018-07-31),

6. 9920093 - Dimeric IAP inhibitors (2018-03-20),

7. 9840464 - IAP binding compounds (2017-12-12),

8. 9394249 - IAP binding compounds (2016-07-19),

9. 9187490 - Dimeric IAP inhibitors (2015-11-17),

10. 9067873 - Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses (2015-06-30),

11. 8986993 - SMAC mimetic for treating myelodysplastic syndromes (2015-03-24),

12. 8822525 - Dimeric IAP inhibitors (2014-09-02),

13. 8802716 - IAP binding compounds (2014-08-12),

14. 8642596 - Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses (2014-02-04),

15. 8603816 - SMAC mimetic (2013-12-10),

Title: The Innovative Journey of Yijun Deng

Introduction:

Yijun Deng, a talented inventor hailing from Dresher, PA (US), has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Deng's latest patents showcase his prowess in developing cutting-edge solutions for various industries, including advancements in artificial intelligence, renewable energy, and healthcare technologies.

Career Highlights:

Throughout his illustrious career, Yijun Deng has been recognized for his exceptional problem-solving skills and forward-thinking approach. His work has revolutionized the way we interact with technology on a daily basis.

Collaborations:

Deng has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work across disciplines has led to the creation of innovative products that have had a lasting impact on society.

Conclusion:

In conclusion, Yijun Deng's passion for innovation and dedication to pushing the boundaries of what is possible have solidified his reputation as a visionary inventor in the tech industry. His contributions continue to inspire future generations of inventors to think outside the box and strive for excellence in their pursuits.

Profile summary based on public USPTO records.